Gerard Brophy - 27 Feb 2023 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
27 Feb 2023
Transactions value $
-$76,475
Form type
4
Filing time
01 Mar 2023, 15:46:31 UTC
Previous filing
27 Feb 2023
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Sale -$76,475 -3,059 -2.64% $25 112,629 27 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.